MOTS-C-MAX-5
Mitochondrial Peptide|5 mg × 10 Vials
An experimental research peptide product containing MOTS-c, a mitochondria-associated peptide investigated in cellular, metabolic, and preclinical research.
Each vial contains 5 mg, with 10 vials per kit, providing a total labeled quantity of 50 mg. Designed for qualified laboratory and research applications, MOTS-C-MAX-5 provides researchers with a clearly identified peptide format suitable for controlled experimental workflows.
Product Highlights
About MOTS-c
MOTS-c is a mitochondria-derived peptide that has attracted interest in experimental research because of its involvement in cellular and metabolic processes.
MOTS-c has been investigated in a range of cellular, biochemical, and preclinical research models, with researchers examining its relationship to metabolic signaling, cellular stress responses, mitochondrial biology, and energy-related pathways.
As an experimental peptide, MOTS-c continues to be investigated to better understand its biological characteristics and mechanisms of action.
Research findings from cellular and animal models should not be interpreted as established evidence of safety or efficacy in humans.
This product is therefore presented as an experimental research compound, rather than an approved therapeutic product.
Product Specifications
| PRODUCT NAME | MOTS-C-MAX-5 |
| COMPOUND | MOTS-c |
| PRODUCT TYPE | Mitochondrial Peptide |
| QUANTITY PER VIAL | 5 mg |
| NUMBER OF VIALS | 10 |
| TOTAL QUANTITY | 50 mg |
| PRODUCT CATEGORY | Research Peptide |
| PHYSICAL FORM | Lyophilized* |
| INTENDED APPLICATION | Laboratory / Research Use |
| PACKAGING | 10-vial kit |
| BRAND | Maxtreme Pharma |
*Confirm the physical form against the manufacturer's current technical documentation before publishing.
Research Applications
MOTS-c has been investigated in experimental research examining its potential role in mitochondrial and cellular biological processes. Research areas may include:
Researchers may also investigate MOTS-c in controlled experimental models to better understand its biological activity and interactions with cellular pathways.
These research areas describe experimental investigation only and do not constitute approved medical indications or recommendations for human use.
MOTS-c Research Profile
MOTS-c is a mitochondria-derived peptide that has been studied as part of research into the communication between mitochondrial function and cellular metabolic processes.
Experimental research has examined its association with pathways involved in cellular metabolism, stress responses, and energy regulation.
Because much of the available evidence remains preclinical, findings from experimental models should not automatically be extrapolated to therapeutic outcomes in humans.
Researchers should consult the relevant scientific literature and product-specific technical documentation when evaluating MOTS-c for research purposes.
Quality & Packaging
The MOTS-C-MAX-5 kit contains 10 individually packaged vials, with 5 mg of labeled peptide per vial, providing a total labeled quantity of 50 mg per kit.
The packaging clearly identifies the product as a mitochondrial peptide and provides the vial strength and kit quantity for straightforward product identification.
For professional research procurement, researchers should verify the applicable Certificate of Analysis (CoA), batch/lot number, peptide identity, purity specifications, testing information, and storage requirements associated with the specific batch.
Storage & Handling
Store and handle MOTS-C-MAX-5 according to the manufacturer's batch-specific technical documentation and Certificate of Analysis.
Peptide stability can be affected by factors including temperature, moisture, light exposure, formulation, and handling conditions.
Researchers should follow the manufacturer's documented storage and handling requirements rather than relying on generic storage recommendations.
Appropriate laboratory procedures and applicable safety protocols should be followed when handling experimental peptide materials.
MOTS-C-MAX-5 is an experimental research peptide and is not presented as a drug, dietary supplement, or approved treatment for any medical condition.
This product is intended for qualified research and laboratory applications in accordance with applicable laws, regulations, institutional requirements, and laboratory safety procedures.
No claim is made that MOTS-c is safe or effective for the diagnosis, treatment, cure, or prevention of any disease or medical condition.
Not for human consumption or self-administration.
Frequently Asked Questions
MOTS-C-MAX-5 is an experimental research peptide product containing MOTS-c, a mitochondria-derived peptide investigated in cellular, metabolic, and preclinical research.
Each vial contains 5 mg of MOTS-c according to the product packaging.
The kit contains 10 vials.
The kit contains 50 mg total, calculated as 10 vials × 5 mg per vial.
MOTS-c is a mitochondria-derived peptide that has been investigated experimentally in areas involving mitochondrial biology, cellular metabolism, and metabolic signaling.
MOTS-c has been investigated in experimental research involving mitochondrial function, cellular energy metabolism, metabolic signaling, and cellular stress responses. These research areas should not be interpreted as established medical applications.
MOTS-c should not be presented as an approved human therapeutic. It remains an experimental research peptide, and preclinical findings do not establish therapeutic safety or efficacy in humans.
No. The product should be presented as For Research Use Only and not for human consumption or self-administration, subject to applicable laws and regulatory requirements.
For professional research procurement, customers should request the applicable Certificate of Analysis (CoA) and batch information. Depending on research requirements, documentation may include information relating to peptide identity, purity, testing, and storage conditions.